BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2665945)

  • 1. Regulation of lymphocyte motility by macrophages: characterization of a lymphocyte migration inhibitory factor derived from a macrophage-like cell line.
    Ye S; Cheung HT
    Cell Immunol; 1989 Aug; 122(1):231-43. PubMed ID: 2665945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous release of leukocyte migration inhibition factor (LMIF) by lymphocytes in chronic lymphatic leukemia patients.
    Crivii SM; Crişan M; Crişan M
    Arch Geschwulstforsch; 1984; 54(1):85-9. PubMed ID: 6367694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of lymphocyte migration by human lymphokines. III. Characterization of a lymphocyte migration inhibitory factor (LyMIF35K).
    McFadden RG; Cruikshank WW; Center DM
    Cell Immunol; 1984 Apr; 85(1):154-67. PubMed ID: 6370461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characteristics of histamine receptor-bearing mononuclear cells. II. Identification and characterization of two histamine-induced human lymphokines that inhibit lymphocyte migration.
    Berman JS; McFadden RG; Cruikshank WW; Center DM; Beer DJ
    J Immunol; 1984 Sep; 133(3):1495-504. PubMed ID: 6379050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of macrophage Fc-dependent phagocytosis by resident thymocytes: effect of a unique heat-stable lymphokine.
    Coleman DL; Root RK; Ryan JL
    J Immunol; 1983 May; 130(5):2195-9. PubMed ID: 6339624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on the pathogenic mechanism of beta-lactam hypersensitivity by the detection of leucocyte migration activating factor and leucocyte migration inhibitory factor].
    Uno K
    Arerugi; 1990 Dec; 39(12):1605-11. PubMed ID: 2096806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of selenium deficiency in goats on lymphocyte production of leukocyte migration inhibitory factor.
    Aziz ES; Klesius PH
    Vet Immunol Immunopathol; 1985 Dec; 10(4):381-90. PubMed ID: 3914136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A spleen-derived maturational factor allows immature thymocytes, prepared as cells bearing low amounts of surface sialic acid, to become cytotoxic T cells.
    Campbell PA; Collins JM; Stedman KE
    J Immunol; 1987 Sep; 139(5):1385-92. PubMed ID: 3114364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Certain characteristics of human lymphocyte migration inhibitory factors (LyMIF) and the effect of ampicillin on their appearance in unstimulated and PHA-stimulated cultures.
    Skopińska-Rózewska E; Madaliński W; Lukasik R
    Acta Physiol Pol; 1983; 34(3):353-67. PubMed ID: 6372368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro assay for responsiveness of lymphocytes to transfer factor by a new leukocyte migration inhibitory test.
    Miyagawa Y; Kawasaki A; Komiyama A; Akabane T
    Microbiol Immunol; 1978; 22(11):701-10. PubMed ID: 370507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The functional characteristics of the interaction of lymphokine-producing lymphocytes with granulocytes of the peripheral blood and skin in dermatosis patients].
    Kozin VM; Adamenko GP; Bogdanovich LI; Iakirevich EV
    Vestn Dermatol Venerol; 1990; (3):29-32. PubMed ID: 2195796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymocyte and macrophage interactions: separation of murine thymocyte subsets and enrichment of syngeneic cell-responding thymocytes by adsorption to macrophage monolayers.
    Wu S; Thomas DW
    J Immunol; 1983 Nov; 131(5):2110-6. PubMed ID: 6226732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the pathogenic mechanism of hypersensitivity to antibacterial agents--correlations of leucocyte migration activating factor and leucocyte migration inhibitory factor with interleukin-2 and interferon-gamma].
    Uno K
    Arerugi; 1993 May; 42(5):656-64. PubMed ID: 8323465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential in vitro effects of etretinate and retinoic acid on the PHA and con A induced lymphocyte transformation, suppressor cell induction and leukocyte migration inhibitory factor (LMIF) production.
    Soppi E; Tertti R; Soppi AM; Toivanen A; Jansén CT
    Int J Immunopharmacol; 1982; 4(5):437-43. PubMed ID: 6215368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocyte migration inhibitory factor (LMIF) induced by concanavalin A: standardized microassay for production in vitro.
    Górski AJ; Dupont B; Hansen JA; Good RA
    Proc Natl Acad Sci U S A; 1975 Aug; 72(8):3197-200. PubMed ID: 1103141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Leukocyte migration inhibiting factor in preparations of alpha and gamma interferons].
    Vakhromeeva NS; Bagaeva LV; Kuznetsov VP; Medunitsyn NV; Bobkova EV
    Vopr Virusol; 1986; 31(5):617-9. PubMed ID: 3026096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A chemotactic factor for rat thymocytes may regulate T-lymphocyte migration toward the thymic microenvironment.
    Imaizumi A; Torisu M; Yoshida T
    Cell Immunol; 1987 Aug; 108(1):53-63. PubMed ID: 3496976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of lymph node cell tube leukocyte adherence inhibition (LAI) reactivity by leukocyte adherence inhibition factor (LAIF).
    Harding MW; Yang TJ
    Cell Immunol; 1984 Aug; 87(1):206-16. PubMed ID: 6204773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of macrophage H2O2 release by resident thymocytes: effect of a soluble factor distinct from interferon-gamma.
    Mellors JW; Bartiss AH; Coleman DL
    Cell Immunol; 1987 Dec; 110(2):391-9. PubMed ID: 3121188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF).
    Kowalczyk D; Staykowa M; Litwora E; Pryjma J; Zembala M
    J Clin Lab Immunol; 1984 Oct; 15(2):105-10. PubMed ID: 6394762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.